KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Total Debt (2016 - 2023)

Historic Total Debt for Chemed (CHE) over the last 15 years, with Q1 2023 value amounting to $21.2 million.

  • Chemed's Total Debt fell 8229.17% to $21.2 million in Q1 2023 from the same period last year, while for Mar 2023 it was $21.2 million, marking a year-over-year decrease of 8229.17%. This contributed to the annual value of $97.5 million for FY2022, which is 4729.73% down from last year.
  • As of Q1 2023, Chemed's Total Debt stood at $21.2 million, which was down 8229.17% from $97.5 million recorded in Q4 2022.
  • In the past 5 years, Chemed's Total Debt ranged from a high of $185.0 million in Q4 2021 and a low of $21.2 million during Q1 2023
  • Its 5-year average for Total Debt is $109.7 million, with a median of $100.8 million in 2022.
  • Per our database at Business Quant, Chemed's Total Debt soared by 6000.0% in 2020 and then crashed by 8229.17% in 2023.
  • Quarter analysis of 5 years shows Chemed's Total Debt stood at $90.0 million in 2019, then soared by 77.78% to $160.0 million in 2020, then rose by 15.62% to $185.0 million in 2021, then tumbled by 47.3% to $97.5 million in 2022, then tumbled by 78.21% to $21.2 million in 2023.
  • Its last three reported values are $21.2 million in Q1 2023, $97.5 million for Q4 2022, and $100.8 million during Q3 2022.